Recent publications published by researchers at the MRC WIMM.
Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity.
Journal article
Hamid MHBA. et al, (2024), Nat Immunol
Accelarated immune ageing is associated with COVID-19 disease severity.
Journal article
Lord JM. et al, (2024), Immun Ageing, 21
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Journal article
(2023), International journal of epidemiology, 53
Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study.
Journal article
Guo L. et al, (2023), Lancet Microbe
Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs.
Journal article
Weeratunga P. et al, (2023), Nat Commun, 14
Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors.
Journal article
Gu X. et al, (2023), EBioMedicine, 98
Long COVID research: an update from the PHOSP-COVID Scientific Summit.
Journal article
Brightling CE. et al, (2023), Lancet Respir Med, 11, e93 - e94
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
Journal article
C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019
SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8+ T cell responses.
Journal article
Wellington D. et al, (2023), Heliyon, 9
Vaccine-induced CD8+ T cells are key to protection from SARS-CoV-2.
Journal article
Antoun E. et al, (2023), Nat Immunol
Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy.
Journal article
Chen Q. et al, (2023), Cell Mol Immunol
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history.
Journal article
Hornsby H. et al, (2023), Nat Commun, 14
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Journal article
Voysey M. et al, (2021), Lancet, 397, 881 - 891